Clinical Trials in Ohio

Showing 17341-17360 of 20,938 trials

Cognitive Therapy in Reducing Depression in Patients With Cancer

NCT01748734

The purpose of this study is to learn about treatment of depression in people who have any type of cancer. Cognitive therapy (CT) helps improve depressive symptoms by targeting patient's thoughts and behaviors. People who are depressed tend to have more negative or pessimistic thoughts. CT helps people evaluate the accuracy of their thoughts. By encouraging patients to develop more balanced views, symptoms of depression begin to improve

Depression

Ohio State University Comprehensive Cancer Center25 participantsStarted Mar 2011

Columbus, Ohio, United States

COMPLETEDPhase 332 miles

Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva

NCT00003325

RATIONALE: Lymphatic mapping may improve the ability to detect cancer of the vulva. PURPOSE: This phase III trial is studying how well lymphatic mapping works in treating patients with stage I or stage II cancer of the vulva.

Vulvar Cancer

Gynecologic Oncology Group515 participantsStarted Dec 1999

Little Rock, Arkansas, United States • Long Beach, California, United States • San Francisco, California, United States +69 more locations

Cognitive Therapy in Reducing Depression in Patients With Cancer

Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva

Find Trials by Condition in Ohio

Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer

A Prospective Observational Study of Epidural Pressures During Caudal Epidural in the Pediatric Population

Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia

Soy Formula Feedings in Healthy, Term Infants

Prevention of Seasonal Affective Disorder

Airway Epithelium Gene Expression: AEGIS IDE

Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF

Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age

A Study of RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (NN25307)

FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only

A New Prenatal Blood Test for Down Syndrome

Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis

Phase III Study to Evaluate Morning Testosterone Normalization in Overweight Men With Secondary Hypogonadism

Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin

Effects of Angeliq and Prempro on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypertension

Pilot Study For Hypothermia Treatment In Hyperammonemic Encephalopathy In Neonates And Very Young Infants

CLCNKA (Ka Renal Chloride Channel[ClC-Ka]) Polymorphism Effects on Hypertrophy Regression

Understanding the Genetic Basis of Atherosclerosis and Peripheral Arterial Disease